Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Pericentric heterochromatin structural integrity is disrupted in the absence of CFDP1 due to loss of core heterochromatin protein, HP1α and H3K9me3 marks. by Gokul Gopinathan (7930679)

“…<i>p</i> value (* < 0.05, ** < 0.01, *** < 0.001). …”

Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

Decreasing trends in HbA1c are visible when using the average HbA1c for each dataset for T1Ds, but not T2Ds. by Hans F. Dias (14486401)

List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

Subjects:

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

CD5-2 decreases established CCM lesions in the hindbrain of <i>Ccm2</i>^<i>ECKO</i> mice and lesions in the retina of <i>Ccm2</i>^<i>ECKO</i> mice. by Jia Li (160557)

Chronic colitis induces marked changes in protein expression in the adult heart and blood. by Yanbo Tang (11457519)

Skin marks is the S1 Fig title. by Mercedes Soto-González (20422078)

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA.... by Emir Matpan (21655811)

“…Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”

Effects of leucettines as DYRK1A inhibitors on cell cycle and cyclin D1 level. by Barbara Pucelik (2988795)

Subjects:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

The influence of selected leucettines on insulin production by 3D MIN6 spheroids. by Barbara Pucelik (2988795)

Subjects:

Development of hiPSC-derived β-cells organoids and the effect of leucettines on the insulin production. by Barbara Pucelik (2988795)

Subjects:

Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus. by Simone A. A. Romariz (16541996)

“…<b>D, E)</b> Ceftriaxone-treated CCI mice had a significant increase in SCL1a2 (GLT-1) mRNA in both the cortex and hippocampus. …”

The parameters of gas exchange markedly decreased in maize <i>zmstomagen1/2</i> mutant compared with in wild type (WT). by Juan-Juan Xu (18590868)

The cell viability of CCD 841 CoN, Caco-2, and SW480 cells after treatments at 48 h of 10 μM nonAS-T9/U4_MH, AS-nonT9/U4_MH, AS-T9/U4_MH and no treatment as a control. by Kanpitcha Jiramitmongkon (6297269)

Marking example. by Qingjun Yu (1649473)

“…<div><p>Structural planes decrease the strength and stability of rock masses, severely affecting their mechanical properties and deformation and failure characteristics. …”

Lower HbA1cs are observed in Type 1, but not Type 2, diabetic subjects post-BCG treatment for bladder cancer. by Hans F. Dias (14486401)

“…<p>For T1Ds, all three datasets (MSA, RPDR and OL) show a reduction in HbA1c, calculated as percentage change in HbA1c values post-BCG instillation. …”

Deletion of Ssp2 or/and Gsk3/Gsk31 markedly suppressed CLZ, TER or CoCl₂-induced Sre1 activity. by Hao Miao (1742044)

“…<p>The Δ<i>ssp2</i>, Δ<i>gsk3</i>Δ<i>gsk31</i>, Δ<i>ssp2</i>Δ<i>gsk3</i>, Δ<i>ssp2</i>Δ<i>gsk31</i> or Δ<i>ssp2</i>Δ<i>gsk3</i>Δ<i>gsk31</i> cells showed a significant decrease in Sre1 activity and delay in the peak rising of the SRE2 reporter stimulated with 8 μg/ml CLZ (A)_, 8 μg/ml TER (B) or 0.32 mM CoCl₂ (C). …”